These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6685641)

  • 1. Results of endocrine therapy do not predict response to chemotherapy in advanced breast cancer.
    Steiner R; Stewart JF; Rubens RD
    Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1559-63. PubMed ID: 6685641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adriamycin alone or combined with vincristine in the treatment of advanced breast cancer.
    Steiner R; Stewart JF; Cantwell BM; Minton MJ; Knight RK; Rubens RD
    Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1553-7. PubMed ID: 6357805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy.
    Mundt AJ; Sibley GS; Williams S; Rubin SJ; Heimann R; Halpern H; Weichselbaum RR
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):151-60. PubMed ID: 8083108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination chemo-endocrine therapy of metastatic and stage IV breast cancer with cyclophosphamide, adriamycin, prednisolone and tamoxifen (CAPT)--with special reference to management of brain and liver metastasis].
    Nakamura Y; Kawaguchi M; Hata A; Watanabe H; Ueki Y; Oribe T; Koba F; Takamuku K
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):243-50. PubMed ID: 2919892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy of advanced breast cancer. Comparison of dibromodulcitol, doxorubicin, vincristine, and fluoxymesterone to thiotepa, doxorubicin, vinblastine, and fluoxymesterone: an Eastern Cooperative Oncology Group Study.
    Skeel RT; Andersen JW; Tormey DC; Benson AB; Asbury RF; Falkson G
    Cancer; 1989 Oct; 64(7):1393-9. PubMed ID: 2505919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction chemotherapy of dibromodulcitol, Adriamycin, vincristine, tamoxifen, and Halotestin with methotrexate in metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1181).
    Chang AY; Putt M; Pandya KJ; Harris J; Gelman R; Tormey DC; Falkson G
    Am J Clin Oncol; 1998 Feb; 21(1):99-104. PubMed ID: 9499270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy versus chemotherapy plus hormonotherapy in postmenopausal advanced breast cancer patients. A randomized trial.
    Viladiu P; Alonso MC; Avella A; Beltrán M; Borrás J; Ojeda B; Bosch FX
    Cancer; 1985 Dec; 56(12):2745-50. PubMed ID: 3902200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined versus sequential chemo-endocrine therapy in advanced prostate cancer: final results of a randomized Southwest Oncology Group study.
    Osborne CK; Blumenstein B; Crawford ED; Coltman CA; Smith AY; Lambuth BW; Chapman RA
    J Clin Oncol; 1990 Oct; 8(10):1675-82. PubMed ID: 2213104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A randomized trial of endocrine therapy, chemotherapy, and chemo-endocrine therapy in advanced breast cancer].
    Tashiro H; Nomura Y; Hisamatsu K
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2369-73. PubMed ID: 2260873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Present status of endocrine therapy of breast cancer: a surgeon's view].
    Nomura Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):981-8. PubMed ID: 6426405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial in postmenopausal patients with advanced breast cancer comparing endocrine and cytotoxic therapy given sequentially or in combination. The Australian and New Zealand Breast Cancer Trials Group, Clinical Oncological Society of Australia.
    J Clin Oncol; 1986 Feb; 4(2):186-93. PubMed ID: 2868074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer.
    Kijima T; Fujii Y; Yokoyama M; Ishioka J; Matsuoka Y; Numao N; Saito K; Koga F; Masuda H; Kawakami S; Kihara K
    BJU Int; 2012 Oct; 110(8):1149-55. PubMed ID: 22369348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of prior adjuvant chemotherapy on survival in metastatic breast cancer.
    Ahmann FR; Jones SE; Moon TE
    J Surg Oncol; 1988 Feb; 37(2):116-22. PubMed ID: 3343839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer. A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age.
    Rose C; Kamby C; Mouridsen HT; Andersson M; Bastholt L; Møller KA; Andersen J; Munkholm P; Dombernowsky P; Christensen IJ
    Breast Cancer Res Treat; 2000 May; 61(2):103-10. PubMed ID: 10942095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of multiple combination chemotherapy with vincristine, cyclophosphamide (Endoxan), methotrexate, 5-fluorouracil, adriamycin and prednisolone (VEMFAH) for advanced breast cancer.
    Kojima T; Hoshino A; Ohara K; Kamiya O; Nagata K; Ito Y; Kinoshita T; Sugiura I; Yamada M; Sato H
    Cancer Chemother Pharmacol; 1985; 15(3):268-71. PubMed ID: 3902267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of advanced breast cancer with two doxorubicin-containing regimens.
    Harris MA; Byrne PJ; Smith FP; Ueno W; Schlesinger C; Oishi S; Schein PS
    Am J Clin Oncol; 1984 Feb; 7(1):51-8. PubMed ID: 6421145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progress in breast cancer chemo-endocrine therapy from the survival standpoint].
    Nomura Y
    Gan To Kagaku Ryoho; 1995 May; 22(6):726-31. PubMed ID: 7755380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary endocrine therapy in locally advanced breast cancers--the Nottingham experience.
    Mathew J; Agrawal A; Asgeirsson KS; Buhari SA; Jackson LR; Cheung KL; Robertson JF
    Breast Cancer Res Treat; 2009 Jan; 113(2):403-7. PubMed ID: 18311583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience.
    Brito RA; Valero V; Buzdar AU; Booser DJ; Ames F; Strom E; Ross M; Theriault RL; Frye D; Kau SW; Asmar L; McNeese M; Singletary SE; Hortobagyi GN
    J Clin Oncol; 2001 Feb; 19(3):628-33. PubMed ID: 11157012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of estrogenic recruitment before chemotherapy in advanced breast cancer: a double-blind randomized study. European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group.
    Paridaens R; Heuson JC; Julien JP; Veyret C; Van Zyl J; Klijn JG; Sylvester R; Mignolet F
    J Clin Oncol; 1993 Sep; 11(9):1723-8. PubMed ID: 8355039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.